ghk-cu 50 mg (50mg Unit) GHK-CU (50mg) – Nordsci

Trust starts with transparency, and we dont believe in gatekeeping

Early-phase and preclinical data suggest that glucagon receptor activation may increase energy expenditure and promote hepatic fat reduction, though the clinical significance of these effects in humans is still being evaluated

That is the evidence gap, stated plainly: the mechanism is well-motivated and the preclinical signal is consistent, but no human study has confirmed that any of it translates to people, at any dose, by any route

1997 Sep-Dec;91(3-5):173-8

Elevated cortisol promotes fat storage, particularly visceral fat around the abdomen

and the placebo effect of elaborate protocols can mask lack of true benefit